
Bryxta 400mg Injection works by inhibiting the formation of blood vessels that supply oxygen and nutrients to tumors, thereby slowing their growth.
Vial
400mg
1 vial
Store in a refrigerator (2 - 8°C)
ZYDUS HEALTHCARE
ZYDUS HEALTHCARE
WHO-GMP & GDP Certified – Meeting Global Pharmaceutical Standards for Trusted International Trade
Procured through authorised distributors and companies, ensuring reliable quality and supply chain traceability.
Active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Pre-dispatch inspection, tamper-evident packing, and documentation verification for every shipment.
Glioblastoma multiforme (brain cancer)
Persistent, recurrent, or metastatic breast cancer
Metastatic cervical cancer
Advanced kidney cancer
At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.
All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.
All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.
"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."
Essential information on active composition, WHO-GMP & GDP certification, cold-chain storage, and international export.
Bryxta 400mg Injection is a certified pharmaceutical product from our Global export catalogue formulated as a Vial (400mg). It contains the active pharmaceutical ingredient Bevacizumab (400mg), manufactured by ZYDUS HEALTHCARE.
Bryxta 400mg Injection is manufactured by ZYDUS HEALTHCARE – WHO-GMP & GDP Certified – Meeting Global Pharmaceutical Standards for Trusted International Trade. ExSell Laboratories delivers authenticated batches sourced through verified, compliant supply channels, backed by complete regulatory documentation.
Bryxta 400mg Injection must be stored according to manufacturer instructions: Store in a refrigerator (2 - 8°C). ExSell Laboratories maintains active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.
Browse certified pharmaceutical formulations and quality-assured brands from our Global export catalogue.

Bevacizumab (400mg)

Bevacizumab (400mg)

Bevacizumab (400mg)

Bevacizumab (100mg/4ml)
Bryxta 400mg Injection
400mg